Literature DB >> 27582863

Pregnancy and multiple sclerosis.

Laura Airas1, Risto Kaaja2.   

Abstract

The relapse rate of multiple sclerosis (MS) is typically reduced during late pregnancy but increases in the postpartum period. The reasons for the increased postpartum activity are not entirely clear, but factors such as the abrupt decrease in oestrogen levels immediately after the delivery and the loss of the immunosuppressive state of pregnancy are likely of importance. There is a general view that MS does not affect the course or outcome of pregnancy.

Entities:  

Keywords:  immunosuppression; multiple sclerosis; pregnancy

Year:  2012        PMID: 27582863      PMCID: PMC4989704          DOI: 10.1258/om.2012.110014

Source DB:  PubMed          Journal:  Obstet Med        ISSN: 1753-495X


  41 in total

1.  Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis.

Authors:  L Airas; A Jalkanen; A Alanen; T Pirttilä; R J Marttila
Journal:  Neurology       Date:  2010-08-03       Impact factor: 9.910

2.  Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy.

Authors:  M Saraste; J Ryynänen; A Alanen; J Multanen; M Färkkilä; R Kaaja; L Airas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

3.  The first case of mitoxantrone exposure in early pregnancy.

Authors:  M De Santis; G Straface; A F Cavaliere; P Rosati; A P Batocchi; A Caruso
Journal:  Neurotoxicology       Date:  2006-10-20       Impact factor: 4.294

4.  Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases.

Authors:  I A Hoevenaren; L C de Vries; R J P Rijnders; F K Lotgering
Journal:  Acta Neurol Scand       Date:  2010-09-16       Impact factor: 3.209

5.  Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland.

Authors:  A Jalkanen; A Alanen; L Airas
Journal:  Mult Scler       Date:  2010-06-11       Impact factor: 6.312

6.  Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis?

Authors:  F Patti; T Cavallaro; S Lo Fermo; A Nicoletti; V Cimino; R Vecchio; P Laisa; R Zarbo; M Zappia
Journal:  J Neurol       Date:  2008-07-28       Impact factor: 4.849

7.  The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha.

Authors:  Magdalena Polanczyk; Alex Zamora; Sandhya Subramanian; Agata Matejuk; David L Hess; Elizabeth P Blankenhorn; Cory Teuscher; Arthur A Vandenbark; Halina Offner
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

8.  Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis.

Authors:  Annette Langer-Gould; Stella M Huang; Rohit Gupta; Amethyst D Leimpeter; Eleni Greenwood; Kathleen B Albers; Stephen K Van Den Eeden; Lorene M Nelson
Journal:  Arch Neurol       Date:  2009-06-08

9.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

10.  Estrogen directly activates AID transcription and function.

Authors:  Siim Pauklin; Isora V Sernández; Gudrun Bachmann; Almudena R Ramiro; Svend K Petersen-Mahrt
Journal:  J Exp Med       Date:  2009-01-12       Impact factor: 14.307

View more
  4 in total

Review 1.  Yoga as an intervention to manage multiple sclerosis symptoms.

Authors:  Priyanka Thakur; Ashu Mohammad; Yash Raj Rastogi; Reena V Saini; Adesh K Saini
Journal:  J Ayurveda Integr Med       Date:  2019-06-24

Review 2.  Extracellular Vesicles in Neuroinflammation.

Authors:  Giulia Marostica; Stefano Gelibter; Maira Gironi; Annamaria Nigro; Roberto Furlan
Journal:  Front Cell Dev Biol       Date:  2021-01-21

Review 3.  Development of New Strategies for Malaria Chemoprophylaxis: From Monoclonal Antibodies to Long-Acting Injectable Drugs.

Authors:  Joerg J Moehrle
Journal:  Trop Med Infect Dis       Date:  2022-04-07

Review 4.  "Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era.

Authors:  Donato Gemmati; Katia Varani; Barbara Bramanti; Roberta Piva; Gloria Bonaccorsi; Alessandro Trentini; Maria Cristina Manfrinato; Veronica Tisato; Alessandra Carè; Tiziana Bellini
Journal:  Int J Mol Sci       Date:  2019-12-31       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.